{"name":"Infectopharm Arzneimittel GmbH","slug":"infectopharm-arzneimittel-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"InfectoScab 5 % Creme","genericName":"InfectoScab 5 % Creme","slug":"infectoscab-5-creme","indication":"Scabies (Sarcoptes scabiei infestation)","status":"phase_3"},{"name":"Permethrin 10 % Creme","genericName":"Permethrin 10 % Creme","slug":"permethrin-10-creme","indication":"Scabies (Sarcoptes scabiei infestation)","status":"phase_3"},{"name":"Solaraze","genericName":"Solaraze","slug":"solaraze","indication":"Other","status":"phase_3"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"SanaCutan Basiscreme","genericName":"SanaCutan Basiscreme","slug":"sanacutan-basiscreme","indication":"Dry skin and skin barrier dysfunction","status":"phase_3"}]}],"pipeline":[{"name":"InfectoScab 5 % Creme","genericName":"InfectoScab 5 % Creme","slug":"infectoscab-5-creme","phase":"phase_3","mechanism":"InfectoScab 5% Creme is a topical scabicide that kills the Sarcoptes scabiei mite and its eggs through direct contact and penetration of the mite's exoskeleton.","indications":["Scabies (Sarcoptes scabiei infestation)"],"catalyst":""},{"name":"Permethrin 10 % Creme","genericName":"Permethrin 10 % Creme","slug":"permethrin-10-creme","phase":"phase_3","mechanism":"Permethrin is a synthetic pyrethroid insecticide that disrupts sodium channel function in the nervous system of parasitic arthropods, causing paralysis and death.","indications":["Scabies (Sarcoptes scabiei infestation)","Head lice (Pediculus humanus capitis)","Body lice (Pediculus humanus humanus)","Pubic lice (Phthirus pubis)"],"catalyst":""},{"name":"SanaCutan Basiscreme","genericName":"SanaCutan Basiscreme","slug":"sanacutan-basiscreme","phase":"phase_3","mechanism":"SanaCutan Basiscreme is a topical emollient and skin barrier repair cream that hydrates and protects damaged or irritated skin.","indications":["Dry skin and skin barrier dysfunction","Irritated or damaged skin conditions"],"catalyst":""},{"name":"Solaraze","genericName":"Solaraze","slug":"solaraze","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNSUl5T1p3RHc4VDlXcjVCd2lvSkw5RllESXhZYmZJSUdSQTBpejgweWZmZjVIMXlLYjBLcXhkelkxd3FrVkJSQUFjSDJSaDRnaTdvOVJkb3FWX0x0RFJsZWFFdTd5eEdKTEZldEI0UlEtNURXV1JlODdCRzkwWUlacDFCNzhsTEM3S0lQM3lmc004dEFoRkQxUnJqcGVFMFJMZFNTZWlHNHhmSWpRNTdpa2w3eGxrV2ZTNE8ySDhGMzZEZk84NGtCQWh4UTM4dw?oc=5","date":"2025-02-13","type":"pipeline","source":"businesswire.com","summary":"InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy - businesswire.com","headline":"InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOdzRNQnBDaWJaajJmeVFWeHZxeHhCRTFQQ2J6ekl4NWRMXzdOVGZNMXowWTFfcVA5bF8xMXB2allyYmN6azBQTmQxZW1ST3d4dnB6ZnpIU2VYWnE4WTl6cmVJQVNvQ1NRN1pScGR1Z3FHV2E5V2liNVh2TnpHam9MbUpIOUlid3BmSDFFdmhac2xVMWJUdG1RMkpha2NERUlZRFRXZE54TUhSd2phS0M4WFEzR1lmUQ?oc=5","date":"2022-05-05","type":"pipeline","source":"Contract Pharma","summary":"Societal CDMO Enters Manufacturing & Supply Agreement with InfectoPharm - Contract Pharma","headline":"Societal CDMO Enters Manufacturing & Supply Agreement with InfectoPharm","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":4},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}